Vantage Investment Partners’s Merck MRK Stock Holding History

Vantage Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-29,348	Closed	-$1.53M	–	94
2018 Q1	$1.53M	Buy	+29,348	New	+$1.59M	0.13%	72

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vantage Investment Partners's MRK Position: Q2 2018 in Review

Vantage Investment Partners sold out of Merck (MRK) in Q2 2018, closing a stake of 29,348 shares — an estimated $1.53M sold.

Vantage Investment Partners first reported a position in MRK in Q1 2018 and held it in 1 quarter. The position peaked at $1.53M in Q1 2018. 2,018 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

Vantage Investment Partners reported no remaining Merck position as of Q2 2018 after selling out during the quarter.
Vantage Investment Partners sold 29,348 Merck shares in Q2 2018, an estimated $1.53M.
Vantage Investment Partners first reported a position in Merck in Q1 2018 and held it in 1 quarter.
Vantage Investment Partners's Merck position peaked at $1.53M in Q1 2018.
2,018 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Vantage Investment Partners's 13F filing for Q2 2018, filed 1 Aug 2018.